These stocks seem expensive now, but in two years you may wish you=?UTF-8?B?4oCZ?=d bought them at these prices

Urgent Buy Alert: FDA Just OK'd Massive Biotech Breakthrough A few years back analyst Jeff Siegel told me to buy Canopy Growth Corp and I sat on his advice. The stock soared from $1.40 a share to $49 a share - a gain of 3,043% -- I really blew it! Now Jeff has found a brand-new opportunity (not cannabis) the FDA has already given the green light to that he thinks could be 10x bigger.   Get the details in this FREE report. Retirement Can Still Be Profitable - Find Out How!  Expert options trader Dave Aquino's e-book "How to Master Retirement Trade" is sending new traders into early retirement. Learn the tricks to spotting the best time to trade each morning when you download the new e-book by clicking here.  Click here now and never miss out on the trades that used to leave beginners guessing. * Top Stock Research Firm Offers FREE Trade Alerts (No Credit Card Needed)... * Deep Dive: Here’s how JPMorgan’s stock under Jamie Dimon has stacked up against other big banks * Deep Dive: These stocks seem expensive now, but in two years you may wish you’d bought them at these prices

Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435 This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.